Percutaneous lines for delivering intravenous antibiotics in people with cystic fibrosis

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 6, 2010, Pages

  Prayle, Andrew P ^a   Hurley, Matthew N ^b   Smyth, Alan R ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

CATHETER REMOVAL; CATHETERS AND TUBES; CYSTIC FIBROSIS; ECHOGRAPHY; HUMAN; INFUSION RELATED REACTION; PAIN; PATIENT SATISFACTION; PERCUTANEOUS LONG INTRAVENOUS LINE; PRIORITY JOURNAL; REVIEW; SHORT INTRAVENOUS LINE; SILASTIC TUBE; SYSTEMATIC REVIEW; THROMBOPHLEBITIS; TREATMENT OUTCOME; BACTERIAL INFECTION; INDWELLING CATHETER; INSTRUMENTATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG DISEASE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CATHETERS, INDWELLING; CYSTIC FIBROSIS; HUMANS; INFUSIONS, INTRAVENOUS; LUNG DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79952067223     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008243.pub2     Document Type: Review

References (16)

1. Lacy DE, Spencer DA, Venkararaman M, Ruiz G, Weller P. Comparison of Two Percutaneous "Midline" Catheters in Cystic Fibrosis. Journal of Intravenous Nursing 1996;16(1):28-31. 6203226
2. Williams J, Smith HL, Woods CG, Weller PH. Silastic catheters for antibiotics in cystic fibrosis. Archives of Diseases in Childhood 1988;63(6):658-9. 3021743
3. Pradeepkumar VK, Waseem R, Shortt C, Barry D, Watson JBG. Home intravenous therapy using a silastic long line catheter in cystic fibrosis patients. Irish Medical Journal 1992;85(3):110-1. 3021745
4. Rahman AKM, Spencer D. Totally implantable vascular access devices for cystic fibrosis. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858]
5. Abedin S, Kapoor G. Peripherally inserted central venous catheters are a good option for prolonged venous access in children with cancer. Pediatric Blood & Cancer 2008;5(2):251-5.
6. Chmiel JF, Davis PB. State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?. Respiratory Research 2003;4:8.
7. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
8. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
9. Higgins JPT, Deeks JJ, Altman DG, on behalf of the Cochrane Statistical Methods Group. Chapter 13: Special Topics in Statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
10. Sterne JAC, Egger M, Moher D, on behalf of the Cochrane Bias Methods Group. Chapter 10: Addressing Reporting Biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
11. Jones SP, Kaslovsky RA. Successful utilization of peripheral inserted central catheters (PICC) for iv antibiotic therapy in pediatric patients with cystic fibrosis (CF) [abstract]. Pediatric Pulmonology 2000;Suppl 20:339.
12. Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ 2006;333(7658):597-600.
13. Mateu E, Calafell F, Ramos MD, Casals T, Bertranpetit J. Can a place of origin of the main cystic fibrosis mutations be identified?. American Journal of Human Genetics 2002;70(1):257-64.
14. O'Sullivan BP, Freedman SD. Cystic Fibrosis. Lancet 2009;373(9678):1891-904.
15. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. Journal of Pediatrics 1998;132(4):589-95.
16. UK Cystic Fibrosis Trust Antibiotic Working Group. Antibiotic Treatment for Cystic Fibrosis. Report of the UK CysticFibrosis Trust Antibiotic Working Group, Third Edition May 2009.